Hyperglycemia Modulates mTOR Signaling and Myelin Protein Expression in Schwann Cells

Area of Science:

• Neuroscience
• Cell Biology
• Endocrinology

Background:

• Diabetic peripheral neuropathy (DPN) is a common diabetes complication.
• Schwann cell dysfunction, demyelination, and impaired nerve regeneration characterize DPN.
• Molecular mechanisms of Schwann cell phenotypic changes under hyperglycemia are not fully understood.

Purpose of the Study:

• To investigate the impact of high glucose on Schwann cell phenotype.
• To determine the role of the mTOR signaling pathway in high glucose-induced Schwann cell changes.

Main Methods:

• Primary rat Schwann cells were cultured in varying glucose concentrations (5 mM, 25 mM, 50 mM).
• Immunofluorescence staining and CTCF analysis assessed key protein markers (c-Jun, Krox-20, p75NTR, MBP, mTOR, p-mTOR, AKR1B1).

Main Results:

• High glucose significantly reduced myelin basic protein (MBP) expression (p = 0.002).
• Total mTOR and phosphorylated mTOR (Ser2448) levels were significantly altered (p = 0.001 and p = 0.0179, respectively).
• Findings suggest impaired mTOR activation and myelin protein loss under hyperglycemia.

Conclusions:

• Hyperglycemia-induced mTOR dysregulation is a key feature of Schwann cell response.
• Impaired myelin protein expression in Schwann cells contributes to DPN pathogenesis.
• This study provides molecular insights into DPN development.